DTS-201

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDTS-201
Drug Alias NameCPI-0004CPI-0004NaSuper-Leu-Dox
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsProstatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCorixaMedarex Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCorixaDiatos SaMedarex Inc
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksDrugBank